Focus on FOCIS : interleukin 2 treatment associated autoimmunity
A patient from the University of Pittsburgh is presented who developed autoimmunity during IL-2 based combination therapy. IL-2 was originally described as a "T cell growth factor" capable of expanding previously activated T cells, enhancing the cytotoxicity of antigen-specific cytotoxic T...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 127(2008), 2 vom: 28. Mai, Seite 123-9
|
|---|
| 1. Verfasser: |
Moschos, Stergios J
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Mandic, Maja,
Kirkwood, John M,
Storkus, Walter J,
Lotze, Michael T |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2008
|
|---|
| Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.)
|
|---|
| Schlagworte: | Case Reports
Journal Article
Review
Interleukin-2
Dacarbazine
7GR28W0FJI
Temozolomide
YF1K15M17Y |
|---|